The British Broadcasting Corporation (BBC)'s senior editor at the Middle East desk is a former employee at a Central ...
Amgen’s bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback